GROM - RENN LX and THMO among premarket gainers
- ORIC Pharmaceuticals ( ORIC ) +56% on Pfizer collaboration, investment .
- ProQR Therapeutics N.V. ( PRQR ) +38% after expanding RNA editing deal .
- Grom Social Enterprises ( NASDAQ: GROM ) +38% .
- Alvotech ( ALVO ) +13% on filing for Humira interchangeable biosimilar gets FDA action date .
- Renren ( NYSE: RENN ) +11% .
- ThermoGenesis Holdings ( NASDAQ: THMO ) +11% .
- Lion Group Holding ( NASDAQ: LGHL ) +5% .
- LexinFintech Holdings ( NASDAQ: LX ) +5% .
- Edesa Biotech ( NASDAQ: EDSA ) +5% .
For further details see:
RENN, LX and THMO among premarket gainers